Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:CE 30:5)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003758 AN006170 Untargeted lipidomics of gemcitabine-resistant cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003757 AN006168 Untargeted lipidomics of gemcitabine-resistant PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003328 AN005453 Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular lipidomics Stem cells Human Multiple sclerosis University of Colorado Denver LC-MS
ST002452 AN004007 Lipidomic analysis of human brain from frontotemporal dementia cases of with GRN and C9orf72 mutations Brain Human Dementia University of Sydney LC-MS
ST001725 AN002810 Lipidomics dataset of Danio rerio optic nerve regeneration model Eye tissue Zebrafish Eye disease University of Miami LC-MS
ST001210 AN002014 Comprehensive UHPLC-MS/MS lipidomics profiling to study effects of betulin on keratinocytes Keratinocytes Human Eberhard Karls University of Tübingen LC-MS
  logo